AI Is Already Inside the Equipment or System. Is Your Validation Strategy Ready?

A practical guide to audit trail, model control, supplier oversight, and validated state for AI embedded in GxP equipment.
AI & VALIDATION

In your next project, the equipment may arrive with AI already embedded.

The professional who knows what to ask before release becomes the person others trust when the technology gets difficult.

AI is moving into laboratory and production equipment. That creates a new validation challenge: the regulated company may use the equipment, but the supplier may control the model, the software updates, and much of the technical evidence.

You do not need to become a data scientist. You do need to know the questions that protect the validated state.

1. Before audit trail, ask whether the model can remain validated

First: does the AI affect GxP? Consider data integrity, product quality, patient/consumer safety, or a GxP-relevant result or decision.

Second: is the model locked or adaptive? A locked model can be identified, tested, released, and kept under change control. A model that keeps learning during routine use may change after validation.

Important: The draft EU GMP Annex 22 focuses on static AI/ML models and states that continuously learning models should not be used in critical GMP applications. Until the guidance is finalized, companies should rely on existing GxP principles and closely follow the evolution of AI/ML regulatory guidance.

The key question is not only whether AI works, but whether its validated state can be maintained.

2. What should be traceable?

For AI embedded in equipment, think beyond the traditional user audit trail. At minimum, the control strategy should let you answer:

  • Which model and version are running?
  • Was the model, firmware, software, decision limit (the point at which the AI changes its classification or result, threshold), or configuration changed?
  • When did the change happen, who approved it, and what was the impact?
  • Can relevant inputs and outputs be reconstructed when needed?
  • Are performance criteria and acceptance limits defined for the intended use?
  • Can supplier actions that affect the validated state be identified and assessed?

3. What if the supplier owns the “black box”?

This is common. The regulated user may not have access to the source code, training pipeline, or internal model history.

The answer is not automatically to demand the source code. The answer is to obtain enough evidence to understand the intended use, identify the approved model, verify performance, assess risk, and control changes.

If the equipment is already installed

Perform a documented gap and risk assessment. Confirm the model type, version, change history, available records, performance evidence, and supplier controls.

If a required control is missing, handle the gap through the quality system according to risk; a deviation or CAPA may be appropriate.

For the next purchase

Include AI requirements into the URS, supplier assessment, technical/quality agreement, and procurement process.

Define expectations for model versioning, change notification, traceability, performance evidence, data integrity, and access to validation-relevant documentation.

The career advantage

Modern validation is becoming less about filling documents and more about making good, risk-based decisions around complex technology.

When you can explain AI/ML validation clearly, challenge a supplier intelligently, and protect the validated state, you become visible as someone ready for more complex projects, technical leadership, and broader responsibility. That is the kind of expertise that builds professional credibility.

 

FAQ: AI embedded in GxP equipment

What is embedded AI in equipment?
It is an AI/ML model built into the software or firmware of an instrument or machine and used to classify, predict, detect, optimize, or support decisions.
Does every AI model in equipment need validation?
No. Start with GxP impact. If the AI can affect data integrity, product quality, patient/consumer safety, or a GxP-relevant decision, it should be included in the validation and risk-management strategy.
Can a continuously learning AI model be used in a critical GxP application?
The 2025 draft EU GMP Annex 22 says dynamic models that continuously and automatically learn during use should not be used in critical GMP applications. The text is still draft, so monitor the final requirement.
Does the regulated company need the supplier’s source code?
Not necessarily. The user needs enough evidence to understand the model’s intended use, identify the approved version, verify performance, assess risk, and control relevant changes.
What should an AI audit trail show?
Depending on risk and intended use: model/version identity, relevant changes, approval and release status, key inputs and outputs, human overrides, configuration changes, and supplier actions that can affect the validated state.
What should be added to supplier qualification for AI-enabled equipment?
Ask about model type, version control, updates, change notification, validation evidence, performance monitoring, data governance, cybersecurity, traceability, and the responsibilities of supplier and regulated user.

FIVE Academy

Want to feel more confident when validation meets AI?

FIVE Academy covers modern Computer System Validation from basic to advanced topics, including CSV, FDA CSA, agile and digital validation, GAMP 5® Second Edition, and AI/ML validation in GxP applications.

Build the knowledge to participate in these discussions with confidence, before the next AI-enabled system reaches your validation desk.

EXPLORE FIVE ACADEMY →

Sources

Author Section
Author
Article written by

Silvia Martins

Silvia is Brazilian electrical engineer and entrepreneur with over 23 years of experience in the Life Sciences industry, working mainly in the biotechnology, pharmaceutical, medical device, and cosmetics sectors.

She has an international background with specialized training in GAMP5® and FDA 21 CFR Part 11 in England, SAP® validation in Germany, and data integrity and governance in Denmark. Lives in the Netherlands, Silvia serves as the CEO and co-founder of FIVE Validation, a company dedicated to simplifying regulatory compliance. She is the visionary behind GO!FIVE®, the digital validation platform, and is also responsible for the content of the FIVE Academy training platform.

Her work focuses on accelerating and optimizing processes with robustness, traceability, and compliance, supporting companies in integrating the ESG culture, particularly in the Social (S) and Governance (G) pillars. Beyond her corporate role, Silvia is available to connect companies from anywhere in the world with the Pastoral do Menor de Sorocaba, in São Paulo state, Brazil, an institution aligned with the United Nations’ Sustainable Development Goals (SDGs) and recognized for its social impact, benefiting more than 1,400 children and adolescents in vulnerable situations every day.

Author Section
Author
Article reviewed by

Lílian Ribeiro

Lílian Ribeiro is a chemical engineer, biomedical systems technologist, postgraduate in Integrated Management Systems, and Data Science and Business Analytics. She has over a decade of technical and commercial experience in the food, pharmaceutical, and healthcare industries. As an advocate for paperless validation, Lilian is passionate about introducing efficiency and innovation into life sciences companies. Her vast experience is fundamental in validation and qualification projects, encompassing digital validation, ERP, EQMS, automation (PW) and IT infrastructure qualification.